what is a glp-1/gip Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Curious how GLP-1 and GIP

Trends Endocrinol Metab 2019;30:701-9.ArticlePubMed 104

doi: 10.1016/j.lfs.2022.120370 91 KandaRHiraikeHWada-HiraikeOIchinoseTNagasakaKSasajimaYet al

Investigational triple agonist targeting GLP-1, GIP and glucagon receptors 20mg, 30mg and 40mg lyophilised vials at 98% purity for in vitro research

The common side effects of retatrutide are: Nausea Vomiting Diarrhea Constipation Fatigue Abdominal discomfort Early satiety Injection site reactions Increased heart rate Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Liver problems Severe gastrointestinal issues Major depressive disorder Suicidal ideal Changes in mood and behavior Pancreatitis Low blood sugar levels (hypoglycemia) Cardiac arrhythmias The drug is still not FDA-approved and contraindications have not yet been determined

Take the Greenfield Rd exit from U.S

The Alba and Nexa Syringe Platforms The combination of Alba and Nexa syringes with SHL Medicals autoinjector technology provides a robust solution for sensitive biologics